## CB: Chubb Limited - XLF: Financial Services

### Executive Summary

No thesis match: MRS_20 -0.6% below STRENGTH zone (4.0-10.0%); PEG 2.15 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-4.2% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($285.40)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 3
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. Autonomous Research Adjusts Chubb Price Target to $319 From $310, Maintains Outperform Rating**
- Source: MarketScreener | 20251201T133800 | Bullish | Relevance: 98%
- Autonomous Research has increased its price target for Chubb to $319 from $310, while maintaining an Outperform rating on the stock. This adjustment reflects a positive outlook from the research firm regarding Chubb's performance. The article also mentions other recent analyst actions and company news for Chubb Limited.

**2. Chubb Limited (CB) Stock on November 29, 2025: Institutional Buying, Q3 Beat, and AI Push Shape the Outlook**
- Source: ts2.tech | 20251129T005112 | Bullish | Relevance: 98%
- Chubb Limited (CB) is performing strongly, trading near all-time highs of $296 with a $117 billion market cap, driven by increased institutional buying, a significant Q3 earnings beat, and strategic investments in AI-powered embedded insurance. The company recently declared a $0.97 quarterly dividend, marking its 32nd consecutive annual increase, and authorized a $5 billion share buyback, reinforcing its shareholder-friendly capital return strategy. Despite some insider selling, institutional ownership at 84% underscores confidence in Chubb's stable, long-term growth prospects, supported by robust underwriting and a conservative valuation.

**3. The Hartford Insurance Group, Inc. $HIG Shares Sold by Grantham Mayo Van Otterloo & Co. LLC**
- Source: MarketBeat | 20251130T094743 | Neutral | Relevance: 55%
- Grantham Mayo Van Otterloo & Co. LLC reduced its stake in The Hartford Insurance Group (NYSE:HIG) by 14.8% in Q2, selling 23,643 shares and retaining 136,560 shares valued at $17.33 million. This comes as company insiders have also sold shares, though institutional investors hold a significant 93.42% of the stock. The Hartford recently exceeded EPS estimates, reported a 7.1% revenue increase, and raised its quarterly dividend, leading analysts to rate HIG as a "Moderate Buy" with an average target price of $143.29.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-17 | Morgan Stanley | $300 | $295 | +2% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-17 | Morgan Stanley | main | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 6 ($8.12M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 42.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 8.8% (-0.3%)
- Berkshire Hathaway, : 7.6% (+15.9%)
- Blackrock Inc.: 6.7% (+0.6%)
- State Street Corpora: 4.1% (+0.4%)
- FMR, LLC: 3.0% (-11.2%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-4.2% 5d) with bearish MACD, trend may be turning.
2. Insider selling cluster: $8.1M in recent transactions.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.15 elevated, pricing in significant growth expectations. Quality metrics strong (margin 16%). Balance sheet: strong liquidity (10.9x). Insider selling cluster ($8.1M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $118.2B |
| Beta | 0.52 |
| 52W Range | $252.16 - $306.91 |
| Short Interest | 0.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.15 |
| Forward P/E | 11.2 |
| Current P/E | 12.4 |
| YoY Growth | 11.1% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from 3.6% to -0.6% (-4.2% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 4.6pp (needs >4.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 56.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -0.58% (CS: 44) | Neutral |
| RSI_14 | 56.4 | Neutral |
| MACD Histogram | -0.24 | Bearish |
| vs SMA20 | 1.005x | Above |
| vs SMA50 | 1.033x | Above |
| vs SMA200 | 1.039x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $293.88
- **Stop Loss:** $285.40 (2.9% risk)
- **Target:** $302.36 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 117
- **Position Value:** $34,383.96
- **Portfolio %:** 34.38%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

### Earnings

**Next:** 2026-01-27 (Est: $6.49)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $6.16 | $7.49 | +21.7% |
| 2025Q2 | $5.97 | $6.14 | +2.8% |
| 2025Q1 | $3.23 | $3.68 | +14.0% |
| 2024Q4 | $5.45 | $6.02 | +10.5% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*